Key Financial Data Of Reporting Company

Immuno-Biological Laboratories Co., Ltd. - Filing #7325711

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
812,850,000 JPY
816,701,000 JPY
790,600,000 JPY
794,621,000 JPY
603,855,000 JPY
647,576,000 JPY
531,820,000 JPY
602,749,000 JPY
500,062,000 JPY
576,692,000 JPY
Ordinary profit (loss)
145,815,000 JPY
125,413,000 JPY
65,973,000 JPY
-149,503,000 JPY
-69,963,000 JPY
-243,472,000 JPY
-196,675,000 JPY
-310,511,000 JPY
-503,432,000 JPY
-678,762,000 JPY
Profit (loss)
186,694,000 JPY
-630,968,000 JPY
-123,641,000 JPY
-219,107,000 JPY
-547,128,000 JPY
Share capital
50,000,000 JPY
3,029,041,000 JPY
3,029,041,000 JPY
3,029,041,000 JPY
3,029,041,000 JPY
Total number of issued shares
9,314,590 xbrli:shares
9,314,590 xbrli:shares
9,314,590 xbrli:shares
9,314,590 xbrli:shares
9,314,590 xbrli:shares
Net assets
1,265,311,000 JPY
1,275,111,000 JPY
1,088,416,000 JPY
1,078,616,000 JPY
1,368,348,000 JPY
1,719,385,000 JPY
1,629,282,000 JPY
1,845,193,000 JPY
1,948,457,000 JPY
2,064,300,000 JPY
Total assets
1,618,582,000 JPY
1,585,218,000 JPY
1,394,501,000 JPY
1,434,337,000 JPY
1,705,338,000 JPY
1,997,942,000 JPY
1,838,038,000 JPY
1,962,901,000 JPY
2,372,989,000 JPY
2,439,750,000 JPY
Net assets per share
135.85
136.91
116.86
115.81
146.92
184.61
174.70
197.88
208.97
221.41
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
20.05
20.05
-67.74
-31.10
-13.27
-27.78
-23.52
-34.23
-62.24
-76.00
Diluted earnings per share
Equity-to-asset ratio
0.782 xbrli:pure
0.804 xbrli:pure
0.781 xbrli:pure
0.752 xbrli:pure
0.802 xbrli:pure
0.861 xbrli:pure
0.885 xbrli:pure
0.939 xbrli:pure
0.820 xbrli:pure
0.845 xbrli:pure
Rate of return on equity
0.158 xbrli:pure
0.159 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
26.4 xbrli:pure
26.4 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
133,775,000 JPY
26,458,000 JPY
-93,204,000 JPY
-194,145,000 JPY
-608,746,000 JPY
Net cash provided by (used in) investing activities
-24,496,000 JPY
30,036,000 JPY
-155,629,000 JPY
-17,233,000 JPY
10,818,000 JPY
Net cash provided by (used in) financing activities
991,000 JPY
991,000 JPY
143,998,000 JPY
-216,000,000 JPY
81,195,000 JPY
Cash and cash equivalents
674,969,000 JPY
561,997,000 JPY
449,184,000 JPY
552,022,000 JPY
974,456,000 JPY
Number of employees
57 xbrli:pure
57 xbrli:pure
57 xbrli:pure
57 xbrli:pure
59 xbrli:pure
60 xbrli:pure
63 xbrli:pure
62 xbrli:pure
65 xbrli:pure
58 xbrli:pure
65 xbrli:pure
56 xbrli:pure
Average number of temporary employees
5 xbrli:pure
5 xbrli:pure
5 xbrli:pure
5 xbrli:pure
8 xbrli:pure
8 xbrli:pure
7 xbrli:pure
7 xbrli:pure
9 xbrli:pure
7 xbrli:pure
11 xbrli:pure
9 xbrli:pure
Total shareholder return
0.739 xbrli:pure
0.569 xbrli:pure
0.457 xbrli:pure
0.772 xbrli:pure
0.751 xbrli:pure
Total return on share price index
1.739 xbrli:pure
1.258 xbrli:pure
1.222 xbrli:pure
1.227 xbrli:pure
0.881 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.